Toxicological evaluation of cyclosporin A
- 1 June 1983
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 53 (2) , 107-141
- https://doi.org/10.1007/bf00302721
Abstract
Toxicological studies in a variety of different animal species have shown that cyclosporin A (CS-A) is a unique immunosuppressant, since it does not cause myelotoxic, teratogenic, mutagenic, or carcinogenic effects. This is undoubtedly due to the fact that CS-A produces its immunosuppressive effects by a specific action on T lymphocytes rather than by a cytotoxic mechanism. The incidence of acute inflammatory lesions was also not significantly higher in treated animals than in controls. Clear-cut organ toxicity only occurred in rats and cynomolgus monkeys, where at high doses nephro- and hepatotoxicity were observed.Keywords
This publication has 38 references indexed in Scilit:
- Genotoxicity evaluation of cyclosporin A, a new immunosuppressive agentMutation Research Letters, 1982
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- CYCLOSPORIN ATransplantation, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitroNature, 1980
- MALIGNANT LYMPHOMA IN CYCLOSPORIN A TREATED ALLOGRAFT RECIPIENTSThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in manNature, 1979
- CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MANThe Lancet, 1978
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955